Clinical Trials Browser

Phase 2 × Cognitive Dysfunction × Ibuprofen × Clear all

NCT03186638 2023-09-25

Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With Cancer

Phase 2 Completed

87 enrolled 13 charts

Neoplasms, Cognitive Dysfunction